Life science News and Research

RSS

BioNeutral, KRP complete manufacturing and distribution agreement

BioNeutral Group Inc., a specialty chemical technology-based life science company, announced today that it completed an agreement with Keystone Research and Pharmaceuticals for its proprietary formulations for use in the Veterinary, Dental and Cosmetic markets. The Terms are being held confidential.

6 Jul 2010

Major biological resource centre increases cell line supply capacity with TAP’s automated cryovial filling system

The Automation Partnership (TAP), world leader in the design and development of innovative automation for life science applications announced its Fill-It™, benchtop automated dispensing system, is being used at one of the world's largest biological resource centres to improve the precision of filling and to significantly reduce the time required to dispense cells into large numbers of cryovials.

6 Jul 2010

Fluidigm's IFC platform products help perform digital-PCR measurements on single gene

Utilizing Fluidigm Corporation's Dynamic Array™ and Digital Array™ integrated fluidic circuits (IFCs), Stanford University researchers to have discovered a much larger spectrum of differences between individual cells than has previously been demonstrated. Among these differences are the communication capabilities that emerge from the interactions of genetic circuitry that mediates cell-to-cell communication.

2 Jul 2010

ClinTec International CRO expands US based operations with launch of New York office

UK-based Global Clinical Research Organisation (CRO), ClinTec International has unveiled a significant expansion into the US marketplace, with the launch of its New York office and the appointment of Susan Pavone, Associate Director of US Business Operations.

2 Jul 2010

Vicept completes $16 million Series A financing

Vicept™ Therapeutics Inc., a privately held specialty biopharmaceutical company dedicated to developing the first effective topically applied therapy for erythema (facial redness) of rosacea, announced that it has secured $10 million to complete a total $16 million Series A financing. The Series A was led by Vivo Ventures, Sofinnova Ventures and Fidelity Biosciences.

30 Jun 2010

TAP announces sale of first advanced micro bioreactor system

The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications, today announced it has sold its first advanced micro bioreactor system (ambr™) system to a global antibody therapeutics company, where ambr is being used to help predict how antibody expressing cell lines will behave in large scale bioreactors.

30 Jun 2010

SeqWright, RainDance Technologies partner to offer RainStorm microdroplet-based PCR technology

SeqWright Inc., a world-wide leader in custom genomic and molecular biology services, announced today the expansion of its service portfolio by partnering with RainDance Technologies to offer the company's innovative RainStorm™ microdroplet-based PCR technology. SeqWright recognizes the growing demand from life science researchers for more efficient and cost-effective processes that allow for automated workflows providing greater confidence in results to meet the needs of large-scale resequencing studies.

30 Jun 2010

Linden completes fundraising for LCP II

Linden LLC, a Chicago-based healthcare focused private equity firm, today announced that it has successfully completed fundraising for Linden Capital Partners II, which closed with $375 million of committed capital and exceeded its target of $300 million and initial cap of $350 million.

25 Jun 2010

Cernostics, Geisinger announce personalized healthcare collaboration

Cernostics Inc., a biotechnology firm specializing in advanced cancer diagnostics, and Geisinger Health System, a $2.1 billion integrated health services organization, today announced a partnership in personalized healthcare. They will focus on developing diagnostic technologies to detect subtle differences in the cellular and molecular makeup of patient tissue samples. These technologies promise to more effectively predict disease progression and identify patients who are most likely to be receptive to specific cancer treatments.

22 Jun 2010

Study shows effective and efficient methods for producing recombinant proteins

A shift in the life science market has begun to steer cell culture scientists to re-evaluate their use of native transferrin and iron chelators to pursue recombinant alternatives. Transferrin regulates the uptake, transport and utilization of iron for cellular function, increasing cell growth and productivity. Native transferrin found in bovine or human serum has been widely used in cell culture for these added benefits. However, regulatory issues continue to arise with the use of native transferrin due to blood-borne pathogens.

21 Jun 2010

Gary and Mary West Foundation announces $25M commitment to West Wireless Health Institute

The Gary and Mary West Foundation today announced a $25 million commitment to enable the West Wireless Health Institute (WWHI) to amplify its aggressive recruitment of world class engineering talent and accelerate its mission on a national and global scale. The additional funding comes on the heels of a $20 million grant announced last month, and brings the total support provided by the foundation to nearly $100 million since the Institute's inception in March 2009.

19 Jun 2010

Life Technologies announces product launches in concert with ISSCR 8th Annual Meeting

Life Technologies Corporation, a provider of innovative life science solutions, today announced activities and product launches in concert with the International Society for Stem Cell Research (ISSCR) 8th Annual Meeting that highlight the company's offerings of complete end-to-end solutions for stem cell research. Stem cell research has been shown to be a critical component of regenerative medicine; a basis for identifying drug targets and drug screening; and an important step in the development of therapies to treat a variety of diseases.

18 Jun 2010

BioNeutral announces distribution collaboration for sporicidal formulations with Steri-7

BioNeutral Group, Inc., a specialty chemical technology-based life science company, announced today that in collaboration with Steri-7™, a UK-based specialty chemical health care company, it will be expanding availability of its sporicidal formulations in the UK, Europe and the Middle East. Steri-7™ recently obtained approval from the UK's National Health Service (NHS) to market its formulations as a sporicidal cleaner/wipe.

17 Jun 2010

Life Technologies forms GIBCO Cell Therapy Systems

Life Technologies Corporation today announced the formation of GIBCO® Cell Therapy Systems (CTS™), which will offer the life science industry's widest array of products to support cell therapy applications, including regenerative medicine. Specifically designed to help cell therapy practitioners accelerate the transition from research to clinical applications, the product portfolio will include a broad and deep offering of Invitrogen devices and reagents.

16 Jun 2010

ATMI introduces new range of single-use bioprocess vessels

ATMI, Inc. today unveiled an important extension to its Integrity™ product line for the biopharmaceutical and biotechnology industries with the introduction of a new range of single-use bioprocess vessels (BPVs). The Integrity BPVs were launched at the IBC Single-Use Applications for Biopharmaceutical Manufacturing event, taking place now through Wednesday, June 16, 2010.

15 Jun 2010

SIRS-Lab, Analytik Jena partner in molecular sepsis diagnostics

SIRS-Lab GmbH and Analytik Jena AG, also based in Jena, will be strengthened by working together in the field of molecular sepsis diagnostics. As part of this cooperation, Analytik Jena subsidiary AJ Innuscreen GmbH will provide the partner with a platform for automated isolation of nucleic acids with the associated reagent system worth almost half a million euro.

15 Jun 2010

BioScale secures $25 million for commercialization of ViBE protein analytics systems

BioScale Inc., a privately-held life science company that develops, manufactures and promotes a new generation of protein analytics technology, today announced that it has secured $25 million in its recent financing round. Led by new investor Morningside Venture, this round will be used to expand manufacturing operations and commercial sales of the ViBE protein analytics systems. Also participating in the financing were existing investors New Science Ventures, WFD Ventures, F2 Ventures, and several individual investors

14 Jun 2010

Despite economic downturn, NJ biotechnology industry continues to grow

The number of biotechnology companies operating in New Jersey continues to increase significantly despite the downturn in the economy, ongoing difficulties in obtaining venture capital and other forms of funding and a contraction in the biotechnology and pharmaceutical industries at both the state and national levels, according to initial results from an industry survey released today by BioNJ, the trade association for the biotechnology industry in New Jersey.

14 Jun 2010

Nativis awarded patents in Japan, China, India for drug signal technology

Nativis, Inc., a La Jolla, Calif.-based life science company, has been issued patents in Japan, China and India for its innovative technology that captures the unique signals of approved drugs at the atomic level and then delivers the signal in a solution to treat serious illnesses. The technology, which also has U.S., Canadian and Australian patents, promises to transform the treatment of diseases, including those for which there are no known cures, such as brain cancer.

10 Jun 2010

IBM, ProtonMedia enter teaming agreement for 3-D virtual collaboration platform

IBM and ProtonMedia have entered into a teaming agreement that will result in the delivery of innovative, 3-D virtual collaboration and communication solutions engineered specifically for global life sciences organizations. Under the terms of the agreement, ProtonMedia's ProtoSphere technology will be the basis for customized, 3-D virtual collaboration environments to create high-performance workplaces.

9 Jun 2010

Life science News and Research

BioNeutral, KRP complete manufacturing and distribution agreement

Major biological resource centre increases cell line supply capacity with TAP’s automated cryovial filling system

Fluidigm's IFC platform products help perform digital-PCR measurements on single gene

ClinTec International CRO expands US based operations with launch of New York office

Vicept completes $16 million Series A financing

TAP announces sale of first advanced micro bioreactor system

SeqWright, RainDance Technologies partner to offer RainStorm microdroplet-based PCR technology

Linden completes fundraising for LCP II

Cernostics, Geisinger announce personalized healthcare collaboration

Study shows effective and efficient methods for producing recombinant proteins

Gary and Mary West Foundation announces $25M commitment to West Wireless Health Institute

Life Technologies announces product launches in concert with ISSCR 8th Annual Meeting

BioNeutral announces distribution collaboration for sporicidal formulations with Steri-7

Life Technologies forms GIBCO Cell Therapy Systems

ATMI introduces new range of single-use bioprocess vessels

SIRS-Lab, Analytik Jena partner in molecular sepsis diagnostics

BioScale secures $25 million for commercialization of ViBE protein analytics systems

Despite economic downturn, NJ biotechnology industry continues to grow

Nativis awarded patents in Japan, China, India for drug signal technology

IBM, ProtonMedia enter teaming agreement for 3-D virtual collaboration platform

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News